BioNordic A/S: Financial statements 2024
CVR: 40831622
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
BioNordic A/S (CVR 40831622) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 59,211,773 and a net result of DKK -20,860,483 compared with DKK 24,548,584 the year before. That is a decrease of 38% compared with the year before. Equity in the 2024 report amounted to DKK 31,024,518. The solvency ratio was 7.9%. The company had 77 employees in the financial year.
- Gross Profit
- DKK 59,211,773
- Profit/Loss
- DKK -20,860,483
- Equity
- DKK 31,024,518
- Total Assets
- DKK 394,856,825
- Employees
- 77
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 59.2M | -20.9M | 31M | 77 |
| 2023 | - | 95.6M | 24.5M | 48.9M | 83 |
| 2022 | - | 77.8M | 5.2M | 24.8M | 98 |
| 2021 | - | 40.3M | 408K | 18.2M | 84 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
BioNordic A/S has published its annual report for 2023. Gross profit came to DKK 95,559,123, and the net result was DKK 24,548,584.
About BioNordic A/S
BioNordic A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Troels Zakarias Glahn Kristiansen. The board consists of Ole Bødtker Nielsen (chair), Lene Ploug Bülow and Nicolas Bødtker Nielsen. The company's owners include Ole Bødtker Nielsen, Stefan Bødtker Michelsen and Nicolas Bødtker Nielsen. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 49,188,844 and a net result of DKK 131,702,212 compared with DKK -20,860,483 the year before. Equity in the 2025 report amounted to DKK 163,782,004.